Pharmaceutical and biotechnology major, Wockhardt has received final approval from the United States Food & Drug Administration for marketing the cardiac drug.
Analysts are eyeing bigger launches that will positively impact company's fortunes.
Currency played an important role in Q2, with US dollar, Japanese yen and euro appreciating vis-a-vis the Indian rupee, while the Brazilian real, South African rand and Russian ruble depreciating against rupee.
The rap from both the US and UK drug regulators, including the latest one from the latter, has hit the scrip.
Another year of strong performance by these export-oriented sectors likely as US economy revives and rupee is expected to be under pressure.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances